0000899243-20-013004.txt : 20200513 0000899243-20-013004.hdr.sgml : 20200513 20200513171531 ACCESSION NUMBER: 0000899243-20-013004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200511 FILED AS OF DATE: 20200513 DATE AS OF CHANGE: 20200513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37609 FILM NUMBER: 20874193 MAIL ADDRESS: STREET 1: 333 ALLERTON AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia, Inc. CENTRAL INDEX KEY: 0001552451 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 1000 SIERRA POINT PARKWAY CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: MyoKardia Inc DATE OF NAME CHANGE: 20120618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-11 0 0001552451 MyoKardia, Inc. MYOK 0001413822 GIANAKAKOS ANASTASIOS C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005 1 1 0 0 President and CEO Common Stock 2020-05-11 4 S 0 600 98.6883 D 63522 D Common Stock 2020-05-11 4 S 0 1700 100.5056 D 61822 D Common Stock 2020-05-11 4 S 0 18581 101.9044 D 43241 D Common Stock 2020-05-11 4 S 0 3519 102.5635 D 39722 D Common Stock 2020-05-11 4 S 0 600 103.33 D 39122 D Common Stock 129407 I By Reporting Person's Trust 2 Common Stock 300000 I By Reporting Person's Trust 4 Common Stock 7000 I By Reporting Person's Trust 5 Common Stock 10000 I By Reporting Person's Trust 6 Common Stock 53087 I By Trust 1 Common Stock 53087 I By Trust 2 Common Stock 53087 I By Trust 3 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Represents the weighted average sale price of the shares sold ranging from $98.50 to $99.46 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in this footnote and footnotes 4 through 7. Excludes 10,000 shares previously owned directly which were contributed on May 6, 2020 to the MJA Legacy Trust, of which the Reporting Person's children are beneficiaries. Represents the weighted average price of the shares sold ranging from $100.01 to $100.94 per share. Represents the weighted average price of the shares sold ranging from $101.07 to $102.05 per share. Represents the weighted average price of the shares sold ranging from $102.11 to $103.09 per share. Represents the weighted average price of the shares sold ranging from $103.19 to $103.54 per share. Excludes 1,000 shares previously held by The TKG Trust dated November 2, 2006 which were redistributed back to the Reporting Person directly and immediately transferred to The TKG 2020 Irrevocable Trust on May 5, 2020. Includes 1,000 shares previously held by The TKG Trust dated November 2, 2006 which were redistributed back to the Reporting Person directly and immediately transferred to The TKG 2020 Irrevocable Trust on May 5, 2020. Includes 10,000 shares previously owned directly which were contributed on May 6, 2020 to the MJA Legacy Trust, of which the Reporting Person's children are beneficiaries. /s/ Cynthia Ladd, as Attorney-in-Fact 2020-05-13